Related Experiment Video
Updated: Aug 24, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Hormone sensitive protocol for metastatic prostate cancer, an update
J L Álvarez Ossorio1, M Rodrigo Aliaga2, A Rodríguez Antolin3
1Servicio de Urología, Hospital Universitario Puerta del Mar, Cádiz, Spain; Asociación Española de Urología (AEU) y Fundación para la Investigación en Urología (FIU).
Abstract:
To review and update last protocols in hormone sensitive metastatic prostate cancer for improving clinical management in routine. Evidence analysis available about recent updates protocols in hormone sensitive metastatic prostate cancer according to expert panel of clinicians about this field. A nominal consensus group for unify and improve the recommendations to the management of sensitive metastatic prostate cancer patients is currently needed. This document unifies and improve the management of patients with hormone sensitive metastatic prostate cancer, with a methodology that combines data quantitative and qualitative and based on the participation of a broad scientific committee appointed by the Spanish Association of Urology.

